Literature DB >> 16438675

Regulating immunity to malaria.

E M Riley1, S Wahl, D J Perkins, L Schofield.   

Abstract

The optimal outcome of a malaria infection is that parasitized cells are killed and degraded without inducing significant pathology. Since much of the pathology of malaria infection can be immune-mediated, this implies that immune responses have to be carefully regulated. The mechanisms by which anti-malarial immune responses are believed to be regulated were discussed at the recent Malaria Immunology Workshop (Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA; February 2005). Potential regulatory mechanisms include regulatory T cells, which have been shown to significantly modify cellular immune responses to various protozoan infections, including leishmania and malaria; neutralising antibodies to pro-inflammatory malarial toxins such as glycosylphosphatidylinositol and haemozoin; and self-regulating networks of effector molecules. Innate and adaptive immune responses are further moderated by the broader immunological environment, which is influenced by both the genetic background of the host and by co-infection with other pathogens. A detailed understanding of the interplay between these different immunoregulatory processes may facilitate the rationale design of vaccines and novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438675     DOI: 10.1111/j.1365-3024.2006.00775.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  89 in total

1.  Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses.

Authors:  Tarun Kumar Bhatt; Sameena Khan; Ved Prakash Dwivedi; Mudassir Meraj Banday; Arvind Sharma; Anmol Chandele; Noelia Camacho; Lluís Ribas de Pouplana; Yang Wu; Alister G Craig; Antti Tapani Mikkonen; Alexander Gerd Maier; Manickam Yogavel; Amit Sharma
Journal:  Nat Commun       Date:  2011-11-08       Impact factor: 14.919

2.  Evolution of parasite virulence when host responses cause disease.

Authors:  Troy Day; Andrea L Graham; Andrew F Read
Journal:  Proc Biol Sci       Date:  2007-11-07       Impact factor: 5.349

Review 3.  Approaches to malaria vaccine development using the retrospectroscope.

Authors:  Vanessa Sardá; David C Kaslow; Kim C Williamson
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 4.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 5.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 6.  Immune mechanisms in malaria: new insights in vaccine development.

Authors:  Eleanor M Riley; V Ann Stewart
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

7.  Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of Retnla expression and secretion.

Authors:  Martha Truscott; D Andrew Evans; Matt Gunn; Karl F Hoffmann
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 9.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

10.  A Plasmodium yoelii soluble factor inhibits the phenotypic maturation of dendritic cells.

Authors:  Jamie M Orengo; Kurt A Wong; Carlos Ocaña-Morgner; Ana Rodriguez
Journal:  Malar J       Date:  2008-12-15       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.